��������

Adlai Goldberg is a seasoned professional with extensive experience in advisory roles, particularly within health sciences and digital innovation. Currently at EY since July 2002, Adlai focuses on supporting emerging cell and gene therapies and leads initiatives such as Pointellis, enhancing the delivery of personalized treatments. Previous roles include establishing EY’s Global Social Media Analytics COE and leading the Performance Improvement consulting practice across the CIS. Prior to EY, Adlai held leadership positions at Arthur Andersen, PCCW, and other organizations, demonstrating a strong track record in experiential design, creative services, and business communications. Adlai possesses an MBA in Marketing and Real Estate from Southern Methodist University and a Bachelor's degree in Accounting from Metropolitan State College.